What does the future hold?
The neuroscience market is growing fast in developed regions.
Increasing occurrences of neurological diseases such as Parkinsonism and Alzheimer’s together with other inherited CNS disorders has increased the need for new developments and improvements in the neuroscience market. Higher uses of imaging machines, intramural imaging tools and other innovative technologies in diagnostics and brain mapping are providing us with a better understanding of neuron functions, allowing us to perform better and more detailed studies.
A global effort has begun to map the brain's functional and structural connections and understand how these maps change in diseases like Alzheimer’s and schizophrenia. Today, some brain scans can detect early signs of Alzheimer’s plaque more than a decade before clinical symptoms appear.
3D Organoid Models
Scientists have begun growing 3D models of human brain tissue that exhibits neural activity. As time progresses, these 3D human brain tissue models may help advance research in discovering new treatments for Alzheimer’s, Parkinson’s, Huntington’s, muscular dystrophy, epilepsy, amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and many other diseases and disorders of the brain. The tools that neuroscience uses for research are evolving in sophistication and stem cells play an important role in the acceleration of progress to benefit humanity.
As our understanding of the brain improves, so does our ability to control it and tap into its networks. Direct connections between the brain and machines, known as brain-computer interfaces, are already allowing paralysed patients to perform simple tasks such as turn thoughts into email or move their hand. Other technologies send information from the outside world directly to the brain, allowing people with damaged eyes and ears to experience sights and sounds around them. As these prosthetics get better, they’ll continue to improve the lives of people with a variety of conditions.